Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

One dose versus two doses of COVID‐19 vaccine for the prevention of breakthrough infections among people previously infected with SARS‐Cov‐2

Journal of Medical Virology(2024)10.1002/jmv.29391Source: DataRank Database

One dose versus two doses of COVID‐19 vaccine for the prevention of breakthrough infections among people previously infected with SARS‐Cov‐2 is a research paper published in Journal of Medical Virology (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.91)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Victor Adekanmbi ORCID,Christine D. Hsu ORCID,Efstathia Polychronopoulou ORCID,Abbey B. Berenson ORCID,Fangjian Guo ORCID

Live enrichment

PubMed:38235834 PMC:PMC10837048 OpenAlex:https://openalex.org/W4390988317

NCI NIH HHS

Grant: K07 CA222343

NICHD NIH HHS

Grant: K12 HD052023

NIAMS NIH HHS

Grant: K12 AR084228

FWCI

0.91

Citation Percentile

0.7%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.29391

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10837048

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.29391

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29391

journalhttps://doi.org/10.1002/jmv.29391

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesVaccine Coverage and HesitancyMedicine

MeSH Terms

ReinfectionCOVID-19SARS-CoV-2COVID-19 VaccinesBreakthrough InfectionsFemaleHumansMale

Keywords

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakConfoundingVaccinationPropensity score matchingVirologyVaccine efficacyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseInfectionVaccineCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being